Cipta Sarana Medika Tbk. vs PP London Sumatra Indonesia Tbk. — how do they compare? Cipta Sarana Medika Tbk. trades at Rp63 (market cap 158.12B, 8.21M 24h volume), while PP London Sumatra Indonesia Tbk. trades at Rp1,325 (market cap 8.93T, 4.69M 24h volume). The key difference: PP London Sumatra Indonesia Tbk. is far larger — about 56.5× Cipta Sarana Medika Tbk.'s market cap, and Cipta Sarana Medika Tbk. is more actively traded (8.21M versus 4.69M). Which is the better fit depends on your goals.
| DKHH | LSIP | |
|---|---|---|
Market Cap | 158.12B | 8.93T |
Volume | 8.21M | 4.69M |
Lot | 82.15K | 46.88K |
Turnover | 515.2M | 6.22B |
Average Price | 62.72 | 1,326.55 |
Value | 515.2M | 6.22B |
Indicative Equilibrium Price | 63 | 1,325 |
Indicative Equilibrium Volume | 1.33K | 1.02K |
Trailing returns across standard periods
Latest headlines on both assets
PT Cipta Sarana Medika Tbk (the Company) was established based on Deed No. 90 dated September 17, 2014 by Dede Fujianti, SH., M.Kn., Notary in Sukabumi. The Company ultimate parent entity is PT Siliwangi Djajakusumah Bersatu. The Company started its commercial operations in 2014.
Read more on DKHH →PT Perusahaan Perkebunan London Sumatera Tbk abbreviated as Lonsum, was established in teh Republic of Indonesia based on Notarial Deed No. 93 of Raden Kadiman dated December 18, 1962 and amended by Notarial Deed No. 20 dated September 9, 1963. Based on Notarial Deed No. 18 of Pahala Sutrisno Amijoyo Tampubolon, S.H., M.Kn., dated May 24, 2013, the Company's shareholders approved the change of the Company's status from Foreign Capital Investment (PMA) company to Domestic Capital Investment (PMDN) company.
Read more on LSIP →